We know that when you make the decision to work with a company to ensure your products are legal and safe, you need to know they have the skills and expertise to trust them and they will go the extra mile for you.
In this blog post, we’re sharing the heritage of Inter Scientific, so you can rest assured that you’re in safe hands when you work with us on any regulatory and analytical testing project.
Our Expert team
Founders David Lawson and Mark Dignum have been actively involved in regulation and analytical testing for over 12 years. Both aren’t afraid to get their hands dirty, actively sharing their knowledge with clients, engaging with regulators, developing the lab and working with the team on a daily basis.
David Lawson, Head of Regulatory, is a biochemist with a reputation for building world-class regulatory teams. He has a long standing experience in participating on expert working groups and influencing policy with governments.
Mark Dignum, Head of Analytical Testing, is a Chartered Chemist and a European Qualified Person with a long career in the pharmaceutical industry. Having set up and audited several EU GMP facilities around the world he now manages our on-site laboratory and ensures that all of our testing is completed to the highest standard.
We have an expanding, cross functional team who were hand-picked for their wealth of expertise gained from working in the pharmaceutical, nicotine delivery and CBD industries that our clients can tap into and specialising in areas including: Biochemistry, toxicology and environmental science.
All of our team members share our core values of professionalism, integrity, ethics and confidentiality and undergo extensive training to uphold these values, provide our clients with exceptional service and improve public health. With each member of our regulatory team being a member of TOPRA – The Organisation for Professionals in Regulatory Affairs.
Our experience making products legal and safe
With a history dating back to 2009, our leadership team pioneered the World’s first and only approved medicinal ENDS device by the MHRA which was subsequently purchased by British American Tobacco in 2014.
Never resting on their laurels, in 2015 the team set up a European GMP Pharmaceutical manufacturing facility, housing both a regulatory team and laboratory to support the development of next-generation nicotine products and medicinal devices – which was soon acquired by Imperial Tobacco.
The same year, David and Mark became directors of Ventus Medical, working to develop the next generation of Nicotine Replacement Therapy (NRT) inhaler devices.
In 2017, they founded Inter Regulatory as a way to provide Electronic Nicotine Device System (ENDS) manufacturers with top-class regulatory consultancy and analytical testing.
Today, Inter Regulatory has grown into what is now known as Inter Scientific, with offices in the UK, US and EU, providing specialist regulatory and compliance services in the pharmaceutical, nicotine, CBD and medical device industries.
Our ongoing dedication to quality
We have gained certifications with and comply with BSI ISO 9001: Quality Management, ISO 14001: Environmental Management Systems, and are working towards our lab being certified by ISO 17025. By operating to these standards, we uphold our commitment to providing the highest quality services and continuously striving to improve our working practices.
Influencing policies in regulation and compliance
As well as helping our clients to comply with regulations, directives and standards, we also play a part in influencing these policies.
Our team members regularly participate in European study groups, consultations and facilitate clinical trials in order to lend their expertise to shaping regulation.
This involvement means that we are ahead of the curve, with specialist understanding of what organisations are looking for when it comes to your products complying with the required scientific regulations and the ability to ensure that your products are on the market safely and legally.
We have worked with multiple committees to lead regulations in e-cigarettes, heated tobacco products, CBD products and other developing industries with ENDS (Electronic Nicotine Delivery Systems), including the project committee of CEN/TC 427 within the European Committee for Standardisation.
If you need help with regulation or analytical testing in the pharmaceutical, nicotine, CBD or medical device areas – we can help.Click here to learn how we can support you, or contact email@example.com to set up an introductory call.
We make regulation simple.
Enter your email address to find out how we can help you get your CBD, nicotine and pharmaceutical products on the market.
We’ll be in touch shortly.